Overview Financials News + Filings Key Docs Charts Ownership Insiders |
Yunhong CTI Ltd. (CTIB)
|
Add to portfolio |
|
|
Price: |
$1.33
| | Metrics |
OS: |
20.1
|
M
| |
|
|
Market cap: |
$26.7
|
M
| |
|
|
Net debt:
|
$4.19
|
M
| |
160.5
|
x Debt/EBITDA
|
EV:
|
$30.9
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
$26.1
|
k
| |
1184.9
|
x EV/EBITDA
|
EBIT
|
|
| |
|
|
EPS |
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
Revenues | 24.1 | 21.1 | 40.5 | 49.4 | 56.2 | 64.3 | 59.4 | 57.8 |
Revenue growth | 14.4% | -48.0% | -18.0% | -12.1% | -12.5% | 8.3% | 2.7% | 3.2% |
Cost of goods sold | 20.3 | 18.0 | 34.2 | 39.4 | 42.5 | 47.1 | 43.0 | 43.6 |
Gross profit | 3.8 | 3.1 | 6.3 | 10.0 | 13.8 | 17.1 | 16.4 | 14.2 |
Gross margin | 15.6% | 14.7% | 15.6% | 20.3% | 24.5% | 26.6% | 27.5% | 24.6% |
Sales and marketing | 0.5 | 0.5 | 1.7 | 4.5 | 5.6 | 6.9 | 6.4 | 5.4 |
General and administrative | 3.8 | 3.7 | 5.4 | 6.1 | 7.7 | 7.4 | 7.1 | 7.2 |
EBIT | -0.5 | -1.0 | -0.6 | -0.4 | 0.6 | 3.0 | 3.0 | 1.8 |
EBIT margin | -2.1% | -5.0% | -1.6% | -0.9% | 1.1% | 4.7% | 5.0% | 3.1% |
Pre-tax income | -7.7 | -2.2 | -4.7 | -2.7 | -1.1 | 1.3 | 1.3 | 0.5 |
Income taxes | 0.0 | -0.4 | 0.1 | 0.8 | 0.7 | 0.7 | 0.4 | 0.2 |
Tax rate | 0.0% | 18.5% | | | | 53.1% | 28.3% | 35.2% |
Earnings from continuing ops | -12.0 | -6.3 | -3.9 | -3.3 | -1.6 | 0.7 | 1.0 | 0.5 |
Earnings from discontinued ops | 0.2 | -2.5 | -3.2 | -0.3 | | | | |
Net income | -11.8 | -8.8 | -7.1 | -3.6 | -1.6 | 0.7 | 1.0 | 0.5 |
Net margin | -49.2% | -41.9% | -17.6% | -7.3% | -2.9% | 1.0% | 1.8% | 0.9% |
|
Diluted EPS | ($2.04) | ($1.34) | ($1.02) | ($0.93) | ($0.44) | $0.18 | $0.30 | $0.15 |
Shares outstanding (diluted) | 5.9 | 4.7 | 3.8 | 3.6 | 3.6 | 3.7 | 3.4 | 3.4 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|